News Overview

The company’s EBITDA surged 78.50% to ₹158.10 Crore in the quarter under review, as compared to ₹88.60 Crore in Q3FY24.

The company reported a 13.70% year-on-year growth in its net profit at ₹341 Crore, against ₹300 Crore in the previous comparable quarter.

Here are some of the stocks that may see significant price movement today: BHEL, IRCTC, Birlasoft, Bajaj Healthcare, etc.

Ipratropium Bromide Nasal Solution (0.03%) is indicated for the symptomatic relief of rhinorrhea (runny nose) associated with allergic and nonallergic perennial rhinitis.

With a revenue potential of ₹350-400 crore, the project would be launched in the early part of FY26.

The stock has gained a total of 28% in the last one year, and 0.79% gain in the last one month.

Top losers in Sensex include Zomato (-5.17%), Power Grid Corp (-3.05%), Tata Motors (-2.62%), Adani ports (-2.24%), and Titan Company (-2.72%).

The company’s operating EBITDA stood at ₹127 Crore, up by 5.30% y-o-y, over ₹120.60 Crore in the previous corresponding period.

As per the reported property consultants, the company has issued a global mandate for selecting candidates for the said land deal.

EBITDA margin increased significantly to 26.8%, while in Q3 FY24 it was 22.5%.